Sabby Management’s Kite Pharma, Inc. KITE Stock Holding History

Sabby Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-31,384	Closed	-$4.37M	–	244
2017 Q2	$3.25M	Buy	+31,384	New	+$2.56M	0.21%	54
2016 Q1	–	Sell	-16,571	Closed	-$803K	–	385
2015 Q4	$1.02M	Sell	16,571 -120,528	-88%	-$8.48M	0.06%	177
2015 Q3	$7.63M	Buy	137,099 +133,427	+3,634%	+$8.39M	0.31%	54
2015 Q2	$224K	Buy	+3,672	New	+$210K	0.01%	297

Sabby Management's KITE Position: Q3 2017 in Review

Sabby Management sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 31,384 shares — an estimated $4.37M sold.

Sabby Management first reported a position in KITE in Q2 2015 and held it in 4 quarters. The position peaked at $7.63M in Q3 2015. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

Sabby Management reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
Sabby Management sold 31,384 Kite Pharma, Inc. shares in Q3 2017, an estimated $4.37M.
Sabby Management first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 4 quarters.
Sabby Management's Kite Pharma, Inc. position peaked at $7.63M in Q3 2015.
244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on Sabby Management's 13F filing for Q3 2017, filed 14 Nov 2017.